Selected pharmacokinetic issues in patients with chronic kidney disease

被引：5
作者：
Churchwell, Mariann D.
Mueller, Bruce A.
机构：
[1] Univ Michigan, Dept Clin Serv, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Univ Toledo, Coll Pharm, Dept Pharm Practice, Toledo, OH 43606 USA
[3] Univ Michigan, Renal Replacement Therapy Kinet Study Grp, Ann Arbor, MI 48109 USA
来源：
BLOOD PURIFICATION | 2007年 / 25卷 / 01期
关键词：
pharmacotherapy; chronic kidney disease; pharmacokinetics;
D O I：
10.1159/000096412
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pharmacotherapy plays an important role in the care of a chronic kidney disease ( CKD) patient but delivering this therapy can be challenging. Besides alterations in the pharmacokinetic parameters of absorption, distribution, metabolism and elimination, the average CKD patient must take multiple medications each day. The likelihood of an adverse drug reaction increases with each medication added to these patients' daily regimen. In this article we discuss selected pharmacokinetic issues unique to CKD patients. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码：133 / 138
页数：6
相关论文
共 50 条
  • [1] Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease
    Scheen, Andre J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (05) : 529 - 550
  • [2] Vaccination issues in patients with chronic kidney disease
    Mathew, Roy
    Mason, Darius
    Kennedy, Jeffrey S.
    EXPERT REVIEW OF VACCINES, 2014, 13 (02) : 285 - 298
  • [3] Diabetes management issues for patients with chronic kidney disease
    Oulahiane, Asmaa
    Anaddam, Sara
    Ouleghzal, Hassan
    Elhaddad, Nadia
    Moussaoui, Souad
    Yaagoubi, Noussaima
    Boufares, Fatima
    Belmejdoub, Ghizlaine
    NEPHROLOGIE & THERAPEUTIQUE, 2012, 8 (03): : 135 - 140
  • [4] Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis
    Velenosi, Thomas J.
    Urquhart, Bradley L.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (08) : 1131 - 1143
  • [5] Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties
    Arnouts, Paul
    Bolignano, Davide
    Nistor, Ionut
    Bilo, Henk
    Gnudi, Luigi
    Heaf, James
    van Biesen, Wim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (07) : 1284 - 1300
  • [6] Regulatory Perspectives on Designing Pharmacokinetic Studies and Optimizing Labeling Recommendations for Patients With Chronic Kidney Disease
    Zhang, Lei
    Xu, Nancy
    Xiao, Shen
    Arya, Vikrain
    Zhao, Ping
    Lesko, Lawrence J.
    Huang, Shiew-Mei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 : 79S - 90S
  • [7] Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease
    Franchi, Francesco
    Rollini, Fabiana
    Been, Latonya
    Maaliki, Naji
    Abou Jaoude, Patrick
    Rivas, Andrea
    Zhou, Xuan
    Jia, Sida
    Briceno, Maryuri
    Lee, Chang Hoon
    Pineda, Andres M.
    Suryadevara, Siva
    Soffer, Daniel
    Zenni, Martin M.
    Bass, Theodore A.
    Angiolillo, Dominick J.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (05) : 452 - 461
  • [8] Pharmacokinetic Characterization of baclofen in Patients With Chronic Kidney Disease: Dose Adjustment Recommendations
    Vlavonou, Raphael
    Perreault, Marc M.
    Barriere, Olivier
    Shink, Eric
    Tremblay, Pierre-Olivier
    Larouche, Richard
    Pichette, Vincent
    Tanguay, Mario
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (05): : 584 - 592
  • [9] Population pharmacokinetic modeling of epoetin delta in pediatric patients with chronic kidney disease
    Knebal, William
    Palmen, Mary
    Dowell, James A.
    Gastonguay, Marc
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (07) : 837 - 848
  • [10] Anticoagulation in Patients with Chronic Kidney Disease
    Elenjickal, Elias John
    Travlos, Christoforos K.
    Marques, Pedro
    Mavrakanas, Thomas A.
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (02) : 146 - 164
12345